OPTIMA PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
OPTIMA PHARMA
Largest movements
- Current assets +€6.3m
up €6.3m (+2453.6%), from €258,260 to €6.6m
of which Receivables within one year: +€6.1m
- Debts +€5.9m
up €5.9m (+2503.9%), from €237,584 to €6.2m
- Profit (loss) carried forward +€399,027
up €399,027 (+744.6%), from €53,586 to €452,614
- Gross operating margin +€778,457
up €778,457 (+759.5%), from €102,501 to €880,959
- Write-downs +€215,500
new in 2020: €215,500
- Taxes +€130,570
up €130,570 (+513.4%), from €25,430 to €156,000
- Staff costs +€111,261
new in 2020: €111,261
From the 2019 result to the 2020 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2019 | 2020 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €297,370 | €6,645,237 | +€6.3m | +2134.7% |
| Fixed assets | 21/28 | €39,110 | €50,202 | +€11,093 | +28.4% |
| Tangible fixed assets | 22/27 | - | €8,243 | +€8,243 | |
| Furniture and vehicles | 24 | - | €8,243 | +€8,243 | |
| Financial fixed assets | 28 | €39,110 | €41,960 | +€2,850 | +7.3% |
| Current assets | 29/58 | €258,260 | €6,595,034 | +€6.3m | +2453.6% |
| Amounts receivable after more than one year | 29 | - | €70,000 | +€70,000 | |
| Trade receivables | 290 | - | €70,000 | +€70,000 | |
| Stocks and contracts in progress | 3 | - | €30,000 | +€30,000 | |
| Stocks | 30/36 | - | €30,000 | +€30,000 | |
| Amounts receivable within one year | 40/41 | €187,000 | €6,296,339 | +€6.1m | +3267.0% |
| Trade receivables | 40 | - | €5,926,249 | +€5.9m | |
| Other amounts receivable | 41 | - | €370,091 | +€370,091 | |
| Current investments | 50/53 | - | €80,582 | +€80,582 | |
| Cash at bank and in hand | 54/58 | €153 | €118,058 | +€117,905 | +77097.1% |
| Deferred charges and accrued income | 490/1 | - | €55 | +€55 | |
| Total equity and liabilities | 10/49 | €297,370 | €6,645,237 | +€6.3m | +2134.7% |
| Equity | 10/15 | €59,786 | €458,814 | +€399,027 | +667.4% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Profit (loss) carried forward | 14 | €53,586 | €452,614 | +€399,027 | +744.6% |
| Amounts payable | 17/49 | €237,584 | €6,186,423 | +€5.9m | +2503.9% |
| Amounts payable within one year | 42/48 | €236,899 | €6,186,423 | +€5.9m | +2511.4% |
| Trade debts | 44 | €45,536 | €5,682,407 | +€5.6m | +12378.9% |
| Suppliers | 440/4 | - | €5,682,407 | +€5.7m | |
| Taxes, remuneration and social security | 45 | - | €407,017 | +€407,017 | |
| Taxes | 450/3 | - | €384,020 | +€384,020 | |
| Remuneration and social security | 454/9 | - | €22,997 | +€22,997 | |
| Other amounts payable | 47/48 | - | €97,000 | +€97,000 | |
| Remuneration, social security and pensions | 62 | - | €111,261 | +€111,261 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €1,501 | +€1,501 | |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €215,500 | +€215,500 | |
| Gross operating margin | 9900 | €102,501 | €880,959 | +€778,457 | +759.5% |
| Operating profit (loss) | 9901 | €68,632 | €552,697 | +€484,064 | +705.3% |
| Financial income | 75/76B | - | €3,759 | +€3,759 | |
| Recurring financial income | 75 | €5,093 | €3,759 | -€1,333 | -26.2% |
| Financial charges | 65/66B | - | €2,237 | +€2,237 | |
| Recurring financial charges | 65 | €6,740 | €2,237 | -€4,504 | -66.8% |
| Profit (loss) for the period before taxes | 9903 | €66,984 | €554,219 | +€487,235 | +727.4% |
| Income taxes | 67/77 | €25,430 | €156,000 | +€130,570 | +513.4% |
| Profit (loss) for the period | 9904 | €41,554 | €398,219 | +€356,665 | +858.3% |
| Profit (loss) for the period to be appropriated | 9905 | €41,554 | €398,219 | +€356,665 | +858.3% |
Source: filed annual accounts (NBB), financial years ended 31 December 2019 and 31 December 2020. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.